cdmo.directory
← Compare landing

Gannet Biochem vs Scinai Immunotherapeutics Ltd.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/gannetbiochem/scinai-immunotherapeutics

CategoryGannet BiochemScinai Immunotherapeutics Ltd.
Listed sitecdmoboth
SummarySpecialized CDMO offering custom polymer science, PEG chemistry, bioconjugation, and cGMP manufacturing services from early discovery through commercial scale, with 30+ years of expertise rooted in Shearwater Polymers and Nektar Therapeutics.Boutique biologics CDMO providing analytical method development, process development, and cGMP manufacturing for biotech clients from early research through Phase 3, backed by over 20 years of experience and state-of-the-art facilities.
Services
  • CMC Analytical Development
  • Analytical Method Development & Validation
  • Formulation Development
  • Process Development
  • Stability Testing & Storage
  • ICH Stability Studies
  • Bioconjugation Services
  • Small Molecule Development & Manufacturing
  • Recombinant Protein Manufacturing
  • Biologics Development & Manufacturing
  • Technology Transfer
  • CMC Regulatory Submission Support
  • CMC Analytical Development
  • Process Development
  • CMC Regulatory Submission Support
  • Technology Transfer
  • Recombinant Protein Manufacturing
  • Biologics Development & Manufacturing
Modalities
  • Small Molecule
  • Biologics (Other)
  • Biologics (Monoclonal Antibodies)
  • Peptide
  • Biologics (Monoclonal Antibodies)
IndicationsData not yet provided.
  • Dermatology
  • Immunology
  • Rare Disease
Locations
  • Headquarters, Huntsville, Alabama, United States
  • Manufacturing Facility, Arab, Alabama, United States
  • Headquarters, Jerusalem, Israel
  • Yavne CDMO Facility, Yavne, Israel
Certifications
  • FDA · Identifier: FDA-registered operations
  • EMA · Identifier: European QP (EMA) audit passed
  • Israeli Ministry of Health · Identifier: Israeli MoH audit passed for Phase 3 clinical trial production
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.